Prepare for your visit

Claudia Gallenstein

Acute Care (Nurse Practitioner) · Huntsville, AL · NPI 1710517867

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$2,489.95

in general payments reported to CMS, 2019-2025 · $1,638 in 2025

The $1,638 reported for 2025 was more than what 93% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).

Who reported paying

General payments only, top 6 by amount.

Astrazeneca Pharmaceuticals LP $481.89
Merck Sharp & Dohme LLC $145.97
Daiichi Sankyo INC. $130.70
Genzyme Corporation $125.00
E.R. Squibb & Sons, L.L.C. $124.65
Genentech, INC. $101.90

Drugs and devices associated with these payments

Lynparza Keytruda Erleada Enhertu Imfinzi Sarclisa Rybrevant Columvi Darzalex Opdivo Doptelet Orserdu

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Claudia Gallenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10475208/claudia-gallenstein